vaccines

Vaccines that prevent infectious diseases.

Industry · 3 companies · 2 report it as a revenue line

Show
8-K events
Match any selected event
8-K event types
More events

Only filters 8-Ks. Other selected forms stay visible.

  • MRK Merck & Co.

    Sells it 16%, $10.1B a year“Human health vaccine products consist of preventive pediatric, adolescent and adult vaccines.”

    Latest 8-KLeadership change ·

    Douglas M. Baker Jr. succeeds Thomas H. Glocer as independent lead director Jan. 1, 2027, ahead of Glocer’s May 2027 board retirement.

  • MRNA Moderna

    Sells it 97%, $1.3B a quarter“Product concentration remains high in COVID vaccines.”

    Latest 8-KPositiveDebt financing ·

    Credit amendment cuts initial and delayed-draw term-loan margins 75 bp and extends maturity to November 2031.

  • PFE Pfizer

    Sells it, part of Product“Vaccines product portfolio across all ages – select products include: the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix and Trumenba.”

    Latest 8-KCEO/CFO change ·

    Interim CFO Cecile Guegan appointed permanent CFO and EVP, effective Nov. 1.

Feedback